Filing Details
- Accession Number:
- 0001645627-17-000048
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-05-02 10:24:31
- Reporting Period:
- 2017-04-27
- Filing Date:
- 2017-05-02
- Accepted Time:
- 2017-05-02 10:24:31
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1528172 | Endonovo Therapeutics Inc. | ENDV | Pharmaceutical Preparations (2834) | 452552528 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1645627 | Scott Michael Mann | 6320 Canoga Avenue Woodland Hills CA 91367 | President | No | Yes | Yes | No |
Transaction Summary
| Purchased: | 30,000 shares | Avg. Price: $0.08 | Total Value: $2,426.50 |
| Number of Shares After Transactions: | 20,479,449 shares | ||
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-04-27 | 1,000 | $0.08 | 20,450,449 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-04-27 | 1,000 | $0.08 | 20,451,449 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-04-27 | 1,000 | $0.08 | 20,452,449 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-04-27 | 1,000 | $0.08 | 20,453,449 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-04-27 | 1,000 | $0.08 | 20,454,449 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-04-27 | 1,000 | $0.08 | 20,455,449 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-04-27 | 1,000 | $0.08 | 20,456,449 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-04-27 | 1,000 | $0.08 | 20,457,449 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-04-27 | 1,000 | $0.08 | 20,458,449 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-04-27 | 1,000 | $0.08 | 20,459,449 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-04-27 | 1,000 | $0.08 | 20,460,449 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-04-27 | 1,000 | $0.08 | 20,461,449 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-04-27 | 1,000 | $0.08 | 20,462,449 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-04-27 | 1,000 | $0.08 | 20,463,449 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-04-27 | 1,000 | $0.08 | 20,464,449 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-04-27 | 1,000 | $0.08 | 20,465,449 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-04-27 | 1,000 | $0.08 | 20,466,449 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-04-27 | 1,000 | $0.08 | 20,467,449 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-04-27 | 1,000 | $0.08 | 20,468,449 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-04-27 | 1,000 | $0.08 | 20,469,449 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-04-27 | 1,000 | $0.08 | 20,470,449 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-04-27 | 1,000 | $0.08 | 20,471,449 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-04-27 | 1,000 | $0.08 | 20,472,449 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-04-27 | 1,000 | $0.08 | 20,473,449 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-04-27 | 1,000 | $0.08 | 20,474,449 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-04-27 | 1,000 | $0.08 | 20,475,449 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-04-27 | 1,000 | $0.08 | 20,476,449 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-04-27 | 1,000 | $0.08 | 20,477,449 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-04-27 | 1,000 | $0.08 | 20,478,449 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-04-27 | 1,000 | $0.08 | 20,479,449 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Billionaire Hedge Funds
